The Biology and Genetics of Your Diagnosis
At a Glance
Laurence-Moon syndrome results from disease-causing changes in both copies of PNPLA6. These changes reduce NTE enzyme function, which can affect retinal cells and hormone-related systems. Diagnosis generally requires changes on both copies; an uncertain result alone does not confirm the condition.
Understanding the biology of Laurence-Moon syndrome requires looking deep inside your cells at a specific protein called neuropathy target esterase (NTE), which is produced by the PNPLA6 gene [1]. While this may sound technical, this “molecular blueprint” is the key to why your body is experiencing specific changes in your vision, balance, and hormones.
The Role of PNPLA6 and the NTE Enzyme
Every cell in your body has a “recycling center” called the endoplasmic reticulum (ER). The PNPLA6 gene provides the instructions to build the NTE enzyme, which lives in the ER [2]. This enzyme’s primary job is to break down and recycle fats (lipids), specifically those called phosphatidylcholine [3].
In Laurence-Moon syndrome, pathogenic variants alter or reduce the function of NTE. Current biological models—which are still under study—suggest this disruption leads to two major problems:
- Cellular Stress: Abnormal processing of fats may stress the internal machinery of cells [4][5].
- Resource Shortage: In the retina, researchers believe the NTE enzyme is responsible for recycling choline, a vital nutrient that light-sensing cells (photoreceptors) need to survive [6]. (Note: this is an active area of study and does not mean that dietary choline is a treatment). Without this recycled choline, the photoreceptors slowly break down, leading to the vision loss characteristic of this condition [6].
Why LMS is Different from Bardet-Biedl Syndrome (BBS)
While both syndromes can affect vision and hormones, they are biologically “night and day”:
- BBS is a Ciliopathy: It is caused by defects in the cilia, the tiny, antenna-like hairs on the outside of cells that act like sensors [7].
- LMS is an Enzymopathy: It is caused by reduced or abnormal function of the internal NTE enzyme that fails to process fats correctly [1].
The “Two-Hit” Rule of Inheritance
Laurence-Moon syndrome is an autosomal recessive condition. This means that to have the syndrome, you must have “pathogenic” (disease-causing) mutations in both of your PNPLA6 gene copies [1]. If both parents are carriers, there is a 25% chance with each pregnancy that a child will inherit the condition.
- Biallelic: This term simply means “both copies” are affected.
- Residual Activity: Research shows that the more the NTE enzyme function is altered, the more likely a person is to experience specific symptoms [8]. For instance, very low levels of enzyme activity are more strongly linked to the vision loss (retinopathy) and hormonal issues (endocrinopathy) seen in LMS [8][9].
A referral to a genetic counselor is highly recommended. They can explain your specific recurrence risks, discuss carrier testing for relatives, and guide you through family planning options and reproductive testing.
Securing a Definitive Diagnosis
To confirm a diagnosis of Laurence-Moon syndrome, a clinical exam is not enough; you need molecular confirmation through genetic testing, such as a targeted gene panel, Whole Exome Sequencing (WES), or Whole Genome Sequencing [10]. Note that WES primarily looks at the protein-coding regions of DNA and can sometimes miss structural or deep-intronic variants, meaning a negative test does not automatically rule out a PNPLA6 disorder.
The Genetic Testing Checklist
When you review your genetic report with your doctor or a genetic counselor, look for these three critical pieces of information to ensure the diagnosis is complete:
- Two Pathogenic Variants: A confirmed diagnosis usually requires identifying pathogenic or likely pathogenic variants in both copies of the gene. If it only finds one, it is possible a second variant exists but was missed by the test [1].
- Confirmed “In Trans”: Because you have two copies of every gene, the lab must confirm that one mutation came from your mother and one from your father [11]. This is called parental segregation. If both mutations are on the same copy (from the same parent), and a second variant isn’t found on the other copy, you are likely a “carrier” and may not have the syndrome. This also applies if you have two copies of the exact same mutation (homozygous).
- Functional Clarification: If the lab finds a VUS (Variant of Uncertain Significance), which is essentially a “genetic typo” where the meaning is unclear, additional review with a clinical geneticist or genetic counselor is needed. A VUS alone does not prove or exclude a PNPLA6 disorder. Do not change your treatment plan or make family planning decisions based solely on a VUS. While specialized labs can sometimes perform an NTE activity assay to see if that specific typo affects the enzyme [8], these are often research-only tests.
By confirming these genetic details, your medical team can move away from general “Laurence-Moon-Bardet-Biedl” labels and provide a plan tailored specifically to the biological reality of your PNPLA6 levels.
Common questions in this guide
What gene is linked to Laurence-Moon syndrome?
How is Laurence-Moon syndrome inherited?
Which genetic tests can confirm a PNPLA6-related diagnosis?
What does “in trans” mean in a genetic report?
Can a VUS confirm Laurence-Moon syndrome?
Can PNPLA6 results predict my symptoms or disease course?
Get notified when new evidence is published on Laurence-Moon syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
PNPLA6 disorders: what's in a name?
Liu J, Hufnagel RB
Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.
PMID: 37732399 - 2
Characterization of the Interaction of Neuropathy Target Esterase with the Endoplasmic Reticulum and Lipid Droplets.
Chang P, He L, Wang Y, et al.
Biomolecules 2019; (9(12)) doi:10.3390/biom9120848.
PMID: 31835418 - 3
The alteration of the expression level of neuropathy target esterase in human neuroblastoma SK-N-SH cells disrupts cellular phospholipids homeostasis.
Hou WY, Song X, Wang Y, et al.
Toxicology in vitro : an international journal published in association with BIBRA 2023; (86()):105509 doi:10.1016/j.tiv.2022.105509.
PMID: 36336212 - 4
Disease-Associated PNPLA6 Mutations Maintain Partial Functions When Analyzed in Drosophila.
Sunderhaus ER, Law AD, Kretzschmar D
Frontiers in neuroscience 2019; (13()):1207 doi:10.3389/fnins.2019.01207.
PMID: 31780887 - 5
ER responses play a key role in Swiss-Cheese/Neuropathy Target Esterase-associated neurodegeneration.
Sunderhaus ER, Law AD, Kretzschmar D
Neurobiology of disease 2019; (130()):104520 doi:10.1016/j.nbd.2019.104520.
PMID: 31233884 - 6
PNPLA6 regulates retinal homeostasis by choline through phospholipid turnover.
Ono T, Taketomi Y, Higashi T, et al.
Nature communications 2025; (16(1)):2221 doi:10.1038/s41467-025-57402-8.
PMID: 40082403 - 7
Hepatic manifestations of ciliopathies: genetic causes and clinical update.
Hegarty R, Zen Y, Sayer JA
European journal of pediatrics 2026; (185(11)).
PMID: 42855640 - 8
Neuropathy target esterase activity defines phenotypes among PNPLA6 disorders.
Liu J, He Y, Lwin C, et al.
Brain : a journal of neurology 2024; (147(6)):2085-2097 doi:10.1093/brain/awae055.
PMID: 38735647 - 9
Novel variants in PNPLA6 causing syndromic retinal dystrophy.
Wu S, Sun Z, Zhu T, et al.
Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.
PMID: 33141049 - 10
Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.
Nanetti L, Di Bella D, Magri S, et al.
Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.
PMID: 35069422 - 11
Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.
Hussain MA, Kumar V, Chapla A, et al.
JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.
PMID: 41356532
This page explains the biology, inheritance, and genetic testing behind Laurence-Moon syndrome for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your results and advise you about diagnosis and family planning.